Vasopressin and Methylprednisolone

for In-Hospital Cardiac Arrest

This is a website for the clinical trial Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest (VAM-IHCA). The information on this site is targeted health-care providers. If you are a patient or relative seeking information, please see Dansk Information (Danish information). Please use the contact information below if there are comments or questions.

NEWS

  • 29/9-21: Main results presented at Critical Care Reviews and published in JAMA!

  • 29/1-21: Enrollment completed

  • 16/9-20: 400 patients included

  • 1/9-20: Trial start in Køge

  • 18/2-20: 300 patients included

  • 9/10-19: 200 patients included

  • 15/5-19: Trial start in Herlev and Gentofte

  • 8/5-19: Trial start in Horsens

  • 1/5-19: Trial start in Viborg

  • 15/4-19: 100 patients included

  • 1/2-19: Trial start in Randers

  • 22/1-19: 50 patients included

  • 21/11-18: Trial start in Odense

  • 20/11-18: First 10 patients included

  • 1/11-18: Trial start at Rigshospitalet

  • 15/10-18: Trial start in Aalborg

  • 17/9-18: Trial start in Aarhus

  • 23/6-18: Website launched